University of Naples Federico II at ISLB 2026
Nov 7–9, 2026 Madrid, Spain ~700 attendees Website
University of Naples Federico II brings 11 presentations to ISLB 2026 in Madrid. Its work spans the clinical use of liquid biopsy across solid tumours, from ESR1 testing and monitoring over time in breast and lung cancer to proteins and RNA as newer markers. One study tests a digital PCR platform that detects several ESR1 mutations at once in real-world samples.
| Organization | ISLB 2026 Attendance |
|---|---|
University of Naples Federico II Naples, Italy | |
Public university in Naples, Italy, with a school of medicine and a teaching hospital. | Talk Sat Nov 7 3:15pm–4:00pm Industry Sun Nov 8 8:15am–9:15am Industry Sun Nov 8 8:15am–9:15am Session Sun Nov 8 9:30am–11:00am Talk Sun Nov 8 9:30am–11:00am Industry Sun Nov 8 12:15pm–1:15pm Industry Sun Nov 8 12:15pm–1:15pm Session Sun Nov 8 3:45pm–5:15pm Talk Sun Nov 8 5:30pm–6:30pm Industry Mon Nov 9 8:00am–9:00am Industry Mon Nov 9 8:00am–9:00am Talk Mon Nov 9 10:00am–11:30am |
Instantly find 20 buyers from University of Naples Federico II
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction